Will new antibiotic Teixobactin save us all?

1 February 2015

Researchers in Germany and the USA have just published a paper in the journal Nature describing a new antibiotic they have called Teixobactin. This study is good news: the World Health Organization warned last year that cancer chemotherapy and routine surgery will soon become life-threateningly risky because of the worldwide rise in antibiotic-resistant superbugs.